Evaluation of Pain With RadiesseĀ® With Lidocaine for Nasolabial Folds (NCT01069354) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of Pain With RadiesseĀ® With Lidocaine for Nasolabial Folds
Canada102 participantsStarted 2012-11
Plain-language summary
To assess pain during nasolabial fold treatment using RadiesseĀ® Injectable Dermal Filler with lidocaine
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Is at least 18 years of age
* Is a candidate for nasolabial fold treatment using Radiesse
* Has approximately symmetrical nasolabial folds
* Understands and accepts the obligation not to receive any other facial procedures in the lower half of the face for 1 month
Exclusion Criteria:
* Has received any type of treatment or procedures including surgery in the nasolabial folds
* Has received neurotoxin, hyaluronic acid, calcium hydroxylapatite (CaHA) or collagen injections in the lower half of the face within past 6 months
* Has received polylactic acid, polymethyl methacrylate (PMMA), silicone or any other permanent filler in the lower half of the face
* Has nasolabial folds that are too severe to be corrected in one treatment session
* Has any history of hypersensitivity to lidocaine or anesthetics of the amide type
What they're measuring
1
Pain Score Using a 10-cm Visual Analog Scale (VAS) for Pain (0 = no Pain, 10 = Very Severe Pain)